The story of Viagra, formerly marketed by copyright, presents a complex case study for stakeholders considering the pharmaceutical website arena . Despite its early success and creation of billions in earnings , the exclusivity end has opened the door for alternative medications, significantly reducing earnings potential . This transition raises qu